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ABSTRACT
Objective: To provide clinical data on a cohort of 6 patients with massive expansion (200 CAG
repeats) of spinocerebellar ataxia type 2 (SCA2) and investigate possible pathways of pathogen-
esis using bioinformatics analysis of ATXN2 networks.
Methods: We present data on 6 patients with massive expansion of SCA2 who presented in
infancy with variable combinations of hypotonia, global developmental delay, infantile spasms,
and retinitis pigmentosa. ATXN2 is known to interact with a network of synaptic proteins. To
investigate pathways of pathogenesis, we performed bioinformatics analysis on ATXN2 com-
bined with known genes associated with infantile spasms, retinitis pigmentosa, and synaptic
function.
Results: All patients had a progressive encephalopathy with autonomic dysfunction, 4 had retinitis
pigmentosa, and 3 had infantile spasms. The bioinformatics analysis led to several interesting
findings. First, an interaction between ATXN2 and SYNJ1 may account for the development of
retinitis pigmentosa. Second, dysfunction of postsynaptic vesicle endocytosis may be important
in children with this progressive encephalopathy. Infantile spasms may be associated with inter-
actions between ATXN2 and the postsynaptic structural proteins MAGI2 and SPTAN1.
Conclusions: Severe phenotype in children with massive expansion of SCA2 may be due to a
functional deficit in protein networks in the postsynapse, specifically involving vesicle endocyto-
sis. Neurology® 2011;77:1055–1060
GLOSSARY
GO  gene ontology; ISS  infantile spasms; OFC  occipital-frontal circumference; RP  retinitis pigmentosa; SCA2 
spinocerebellar ataxia type 2.
Spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant disease associated with expan-
sion of a CAG repeat in ATXN2.1 An expansion size of 33–64 repeats results in adult onset of
slowly progressive ataxia, dysarthria, and eye movement abnormalities.2 Other phenotypes in
adults have included retinitis pigmentosa (RP),3–5 autonomic disturbance,6 hypogonadotropic
hypogonadism,7 and mixed ataxia–parkinsonism.8,9 There are reports of childhood-onset
SCA2 with expansions of 62–75 repeats,10–13 and in some families variation in CACNA1A
modifies age of onset.14
Moderate-sized expansion in ATXN2 results in Purkinje cell degeneration through cellular
dysfunction on multiple levels,15–17 and may include abnormalities in RNA binding and splic-
ing.18 Mice with polyQ-58 mutations in Atxn2 have Purkinje cell degeneration similar to that
seen in patients with adult-onset SCA2.19 Interestingly, knockout mice deficient in Atxn2 are
obese and have abnormal fear conditioning, but have normal neurohistology.20
A single pediatric patient report associated massive expansion (200 repeats) of SCA2 with
progressive encephalopathy, optic atrophy, RP, and early death.21 We present data on 5 addi-
tional patients, including updated clinical information on the patient previously reported. All
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had massive expansion of SCA2 with cortical
and cerebellar degeneration, 4 had RP, 3 had
infantile spasms (ISS), and 2 others had
infant-onset epilepsy. We then used bioinfor-
matics tools to generate hypotheses about
mechanisms of pathogenesis. Given the inter-
action of ATXN2 with a synaptic protein-
protein network18 that includes A2BP1,22 and
the association of A2BP1 with epilepsy and
autism,23,24 we asked whether a network rela-
tionship might exist between the ATXN2 net-
work, the identified genetic causes of RP, the
newly described genes associated with ISS,
and other pathways of synaptic function. We
hypothesize that the severe phenotype of pa-
tients with massive expansion of SCA2 may
be due to a functional deficit in key protein–
protein networks in the postsynapse.
METHODS Patients. Retrospective records from 6 pa-
tients with massive expansion of SCA2 were reviewed,
including EEG reports, brain imaging, and histopathol-
ogy. Analysis of the SCA2 alleles was carried out as de-
scribed1 with additional modifications.25
Standard protocol approvals, registrations, and patient
consents. The study was approved by the institu-
tional review board of the University of Chicago.
Bioinformatic analyses. Role of ATXN2 network in brain
development and function. The genes in the ATXN2
interaction network were investigated for evidence of
brain expression and role in brain development and
function using publicly available Web-based resources,
as detailed in appendix e-1 on the Neurology® Web site
at www.neurology.org.
Network analysis. The genes in the ATXN2 interac-
tion network were next combined with 1) a list of genes
associated with RP; 2) a list of genes associated with ISS;
and, given the known interactions between ATXN2
and synaptic proteins, 3) a list of genes involved in syn-
aptic function. Each combined list was then examined
with a network analysis algorithm to look for evidence
of interactions between the ATXN2 network and
genes/proteins associated with RP, ISS, and synaptic
function, as detailed in appendix e-1.
RESULTS Patient 1. This infant girl was previously
reported.21 She presented with apnea at 2 weeks.
Occipital-frontal circumference (OFC) was 3 SD
at 10 months of age. Ophthalmologic examination
showed RP. SCA2 testing revealed an abnormal allele
with 220 CAG repeats. However, one aspect of her
case not known to the authors of the initial report
was that she developed ISS at 16 months, with hyp-
sarrhythmia on EEG. She died at 2 years from respi-
ratory complications.
Patient 2. This infant girl presented with hypotonia
at 6 months. MRI at 7 months (figure 1, A and B)
showed probable cerebellar atrophy and delayed my-
elination. At 14 months she developed ISS with hyp-
sarrhythmia. She had relative microcephaly (length
25th percentile, OFC 2 SD) and optic nerve atro-
phy. Repeat brain MRI at 17 months (figure 1, C
and D) showed cerebral dysmyelination, enlarged
lateral ventricles, and obvious cerebellar and brains-
tem atrophy. SCA2 testing showed CAG repeat size
of 200. She had autonomic dysfunction, and died
at 22 months from aspiration pneumonia.
Patient 3. This infant boy presented at 3 months with
focal seizures. At 10 months he developed ISS with
hypsarrhythmia. Brain MRI at 10 months showed
prominent sulci frontally, enlargement of the lateral
and third ventricles, and an atrophic-appearing cere-
bellum (not shown). At 12 months he was microce-
phalic, with sluggish pupillary reaction to light.
Ophthalmologic examination diagnosed cortical vi-
sual impairment, and otoacoustic emissions were ab-
sent. He had impaired swallowing and autonomic
instability. SCA2 testing showed a repeat length of
200. He died at 13 months.
Patient 4. This infant girl presented with loss of head
control and poor visual fixation at 3 months and at 5
months she had myoclonic seizures. At 17 months
EEG showed high-amplitude bursts of slow waves
with polyspikes reminiscent of hypsarrhythmia.
Brain MRI at 6 months showed diffuse parenchymal
volume loss and delayed myelination (figure 1, G
and H). She was microcephalic (OFC 3 SD) and
by 21 months was somnolent with minimal visual
interaction. Ophthalmologic examination showed
RP. SCA2 testing showed an expanded allele with
500 CAG repeats. She died at 32 months. Patho-
logic examination of the cerebellum showed reduc-
tion in the thickness of the molecular layer, but
relative preservation of both Purkinje and granular
neurons (figure 2A).
Patient 5. This infant girl was the paternal half-sister
of patient 4. She had global developmental delay in
infancy and was reported to be microcephalic (OFC
not available). At 4 years she was failing to thrive
with poorly coordinated swallow and 10 months
later began to lose motor and cognitive milestones
and had autonomic dysfunction. Brain MRI at 5
years 10 months (figure 1, I and J) showed diffuse T2
white matter signal abnormalities, with cavitations of
the parieto-occipital lobes and cortical and cerebellar
volume loss. Ophthalmologic examination revealed
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optic nerve atrophy and RP. Initial SCA2 testing was
negative, but was repeated due to suspicion that rou-
tine PCR amplification may not detect very large ex-
pansions, with discovery of a median CAG repeat
length of 750.
Patient 6. This infant girl presented at 2 months with
poor head control and lack of visual fixation. At 7
months she had tonic seizures. An EEG at 14 months
showed multifocal epileptiform discharges. At 12
months she was diagnosed with RP. Brain MRI at 12
months (figure 1, K and L) showed mild cerebellar
atrophy. At 13 months a gastrostomy tube was
placed. SCA2 testing showed 300 CAG repeats. The
patient died after a neurodegenerative course. Patho-
logic examination of the cerebellum showed pro-
found loss of Purkinje and granular neurons with
severe attenuation of the molecular layer (figure 2B).
The data on all 6 patients are summarized in table 1.
Bioinformatic analyses. Role of ATXN2 network in brain
development and function. The evidence for each gene
in the ATXN2 network for a role in brain development
and function is shown in table e-1 (see appendix e-1).
This analysis validated the importance of several mem-
bers of the ATXN2 network in gene ontology (GO)
categories important for neurologic development and
function.18,26
Network analysis. Analysis of the genes in the
ATXN2 network combined with genes associated
with RP did not reveal any direct interactions (data
not shown). However, a network relationship be-
Figure 1 Brain MRI scans of patients with massive expansion of SCA2
Axial (A) and sagittal (B) views of patient 2 at 7 months, showing enlarged lateral ventricles, and small brainstem and cerebellum. By 17 months, axial (C) and
sagittal (D) views show progression of cerebral white matter volume loss and dysmyelination, and pontocerebellar atrophy. Axial (E) and sagittal (F) views of
patient 4 at 6 months and again (G) and (H) at 19 months showing worsening cerebral volume loss, abnormal white matter signal, thinning of the corpus
callosum, and pontocerebellar atrophy. Axial (I) and sagittal (J) views of patient 5 at 5 years 10 months showing diffuse T2 white matter signal abnormali-
ties, with parieto-occipital cavitations, thinning of the corpus callosum, and cerebellar volume loss. Axial (K) and sagittal (L) views of patient 6 at 12 months
showing mild volume loss of the anterior cerebellar vermis.
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tween ATXN2 and SYNJ1 suggests a possible mech-
anism for retinal dysfunction in patients with
expansion of SCA2. As several patients in this series
had ISS, we also looked for interactions between the
ATXN2 network and the genes associated with ISS.
A network was found between ATXN2, SYNJ1,
PTEN, MAGI2, and SPTAN1 (figure 3). MAGI2 is
expressed postsynaptically, as is ACTN2, a key mem-
ber of the ATXN2 network.27,28 ACTN2 forms part
of an interaction network with the spectrin protein
SPTAN1, mutations of which have recently been de-
scribed in children with ISS.29 We then analyzed the
ATXN2 network together with proteins involved in
synaptic function, in order to discover additional in-
teractions potentially involved in pathogenesis. Our
analysis identified additional interactions between
ATXN2 and SH3GL2, a member of the GO biolog-
ical process of synaptic vesicle transport.
DISCUSSION Massive expansion of SCA2 is asso-
ciated with a severe neurologic phenotype, with
hypotonia and global developmental delay in the
first year of life. Four of the patients in this report
had RP, which has been described in some patients
with moderate-sized SCA2 expansions as well. Our
bioinformatics analysis identified a hypothetical net-
work relationship between ATXN2 and SYNJ1.
Synj1 has a role in zebrafish retinal function, specifi-
cally in cone photoreceptors,30,31 and it is possible
that impaired ATXN2-SYNJ1 interactions play a
role in the development of RP in patients with ex-
panded SCA2 alleles.
Three of the patients developed ISS, and one of
the others had infant-onset myoclonic seizures with
an EEG with elements of hypsarrhythmia. As ISS can
be associated with mutations in genes with roles in
forebrain development, specifically synaptic func-
tion,29,32–35 we focused our bioinformatics analysis on
discovery of further interactions between the
ATXN2 network and proteins important in synapse
biology. Previous work on the ATXN2 network18,26
supported this approach, and we report additional
possible interactions between ATXN2 and proteins
involved in synaptic vesicle endocytosis, including
SH3KBP1, SYNJ1, DNM1, and AMPH. SYNJ1 has
an additional role in postsynaptic AMPA regula-
tion,36 and through interaction with PTEN connects
Figure 2 Pathologic examination of cerebellum of a patient with massive expansion of SCA2
Photomicrograph (A) of the cerebellar cortex from patient 4. There is a reduction in the thickness of the molecular layer, but
relative preservation of both Purkinje and granular neurons. Photomicrograph (B) of the cerebellar cortex from patient 6.
There is profound loss of Purkinje and granular neurons with severe attenuation of the molecular layer. Both figures stained
with hematoxylin and eosin. Scale bar  100 m.





SCA2 repeat size GDD/age, mo Eye exam Seizures/age, mo
Autonomic
dysfunction
1a 220 Father/43 /7 RP, OA ISS/16 
2 200 Father/42 /2 OA ISS/14 
3 200 Mother/45 /3 CVI Partial sz/3 ISS/10 
4 500 Father/40 /3 RP Myoclonic sz/5 NK
5 750 Father/40 / 12 RP, OA None 
6 300 Father/43 /2 RP Tonic sz/7 
Abbreviations: CVI  cortical visual impairment; GDD  global developmental delay; ISS  infantile spasms; NK  not
known; OA  optic nerve atrophy; RP  retinitis pigmentosa; SCA2  spinocerebellar ataxia type 2; SZ  seizures.
a Patient 1 previously reported.21
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to MAGI2, an anchoring molecule in the postsynap-
tic density associated with ISS.
It remains unclear why children with massive ex-
pansions in SCA2 have a more severe phenotype
than patients with more moderate-sized expansions.
The mechanism may involve a toxic effect of messen-
ger RNA containing the expansion and impairment
of key cellular survival pathways, similar to that
found in myotonic dystrophy type 1.37,38 We specu-
late that this pathway dysfunction may be most dele-
terious at the synapse. Further study will also be
needed to clarify the variable clinical and neuro-
pathologic spectrum seen in this disorder.
We report a severe neurologic phenotype in a group
of 6 patients with massive expansion of SCA2. We used
a bioinformatics approach to generate the hypothesis
that a functional deficit in several important protein
networks in the postsynapse may be involved in patho-
genesis. This hypothesis can be tested in the repeat ex-
pansion mouse model of SCA2, with more severe
phenotypes expected to correlate with abnormal expres-
sion patterns of proteins in the postsynapse.
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